Infect Chemother.  2012 Oct;44(5):331-337. 10.3947/ic.2012.44.5.331.

The Meaning and Impact of Appropriate Use of Antibiotics

• Choi JH

• KMID: 2170376
• DOI: http://doi.org/10.3947/ic.2012.44.5.331

Abstract

Antibiotics, one of the most successful drugs in medicine, dramatically altered the prognoses of patients with bacterial infections. With faith in that power, antibiotics have been used thoughtlessly as therapy or prophylaxis for several decades. Improper or inadequate use of these miracle drugs accelerated the appearance of resistance and aided spread of bad bugs. Resistance is a global problem; therefore, appropriate use of antibiotics is now a global concern. Decreasing unnecessary use of antibiotics in primary care clinics and amending inadequate use in teaching hospitals are essential in the fight against resistance. Many approaches to this fight, including a nationwide campaign, governmental policies, guidelines for antibiotic use, and antibiotic restriction systems have already been settled in many countries, including Korea. Although resistance is a critical problem now and will be even more of a problem in the future, antibiotics are not drugs we can throw away. The only way to overcome this threat is wise use of antibiotics.

Keyword

Antibiotics; Appropriate; Mortality; Resistance

MeSH Terms

Anti-Bacterial Agents
Bacterial Infections
Hospitals, Teaching
Humans
Korea
Primary Health Care
Prognosis
Anti-Bacterial Agents

Reference

1. Ulldemolins M, Nuvials X, Palomar M, Masclans JR, Rello J. Appropriateness in critical. Crit Care Clin. 2011. 27:35–51.

2. Fishman N. Antimicrobial stewardship. Am J Med. 2006. 119:6 Suppl 1. S53–S61.

3. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000. 31:Suppl 4. S131–S138.

4. Vogelaers D, De Bels D, Forêt F, Cran S, Gilbert E, Schoonheydt K, Blot S. ANTHICUS Study Investigators. Patterns of antimicrobial therapy in severenosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates-a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents. 2010. 35:375–381.

5. Schwaber MJ, Carmeli Y. The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy. Crit Care. 2009. 13:106.

6. Rello J, Mallol J. Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen? Chest. 2006. 130:938–940.

7. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001. 33:757–762.

8. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice 1991-1999. Ann Intern Med. 2003. 138:525–533.

9. Kuyvenhoven MM, van Balen FA, Verheij TJ. Outpatient antibiotic prescriptions from 1992 to 2001 in The Netherlands. J Antimicrob Chemother. 2003. 52:675–678.

10. Hulscher ME, van der Meer JW, Grol RP. Antibiotic use: how to improve it? Int J Med Microbiol. 2010. 300:351–356.

11. Kim BN. Overview of antibiotics use in Korea. Infect Chemother. 2012. 44:250–262.

12. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospital: a social and behavioral scientific approach. Lancet Infect Dis. 2010. 10:167–175.

13. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcome in the ICU setting. Chest. 2000. 118:146–155.

14. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003. 123:1615–1624.

15. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D. Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009. 136:1237–1248.

16. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. International Surviving Sepsis Campaign Guidelines Committee. American Association of Critical-Care Nurses. American College of Chest Physicians. American College of Emergency Physicians. Canadian Critical Care Society. European Society of Clinical Microbiology and Infectious Diseases. European Society of Intensive Care Medicine. European Respiratory Society. International Sepsis Forum. Japanese Association for Acute Medicine. Japanese Society of Intensive Care Medicine. Society of Critical Care Medicine. Society of Hospital Medicine. Surgical Infection Society. World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008. 36:296–327.

17. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004. 164:637–644.

18. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006. 34:1589–1596.

19. Deresinski S. Principles of antibiotic therapy in severe infection: optimizing the therapeutic approach by use of laboratory and clinical data. Clin Infect Dis. 2007. 45:Suppl 3. S177–S183.

20. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005. 51:171–176.

21. Goossens H, Ferech M, Vander Stichele R, Elseviers M. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005. 365:579–587.

22. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 1999. 341:233–239.

23. Costelloe C, Metcalfe C, Loveing A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resis tance in individual patients: systematic review and meta-analysis. BMJ. 2010. 340:c2096.

24. Oppong R, Coast J, Hood K, Nuttall J, Smith RD, Butler CC. Resource use and costs of treating acute cough/lower respiratory tract infection in 13 European countries: results and challenges. Eur J Health Econ. 2011. 12:319–329.

25. Huttner B, Goossen H, Verheij T, Harbarth S. CHAMP consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010. 10:17–31.

26. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999. 29:60–66.